(Q33153736)

22 July 2017

Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study (English)

1 reference

22 July 2017

0 references

0 references

0 references

1 reference

George N Theodorakis

1

1 reference

22 July 2017

Dionyssios Leftheriotis

2

1 reference

22 July 2017

Efthimios G Livanis

3

1 reference

22 July 2017

Panagiota Flevari

4

1 reference

22 July 2017

Georgia Karabela

5

1 reference

22 July 2017

Nikolitsa Aggelopoulou

6

1 reference

22 July 2017

Dimitrios Th Kremastinos

7

1 reference

22 July 2017

13 February 2006

1 reference

22 July 2017

1 reference

22 July 2017

8

1 reference

22 July 2017

3

1 reference

22 July 2017

193-198

1 reference

Beta-blockers in syncope: the jury is still out.

22 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Pharmacotherapy of neurally mediated syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

The effectiveness of beta-blockade and its influence on heart rate variability in vasovagal patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Pathophysiology and differential diagnosis of neurocardiogenic syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Long-term follow-up of children and adolescents with syncope; predictor of syncope recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Impairment of physical and psychosocial function in recurrent syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUJ041

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUJ041

1 reference

22 July 2017

1 reference